From scientific discovery to clinical practice: how do we turn evidence into better outcomes?
With over 2,000 publications and 250 scientists mentored, Prof Thomas F. Lüscher has helped shape cardiovascular medicine.
Can ECPR transform outcomes after cardiac arrest - and what does it tell us about UK shock care?
A UK multicentre study co-authored by Dr Barrett examined 2,117 VA-ECMO patients, with 963 surviving at six months. Within this cohort, there were 302 ECPR runs and 92 survivors.
When we support the circulation during high-risk PCI, does that translate into better outcomes?
At #SHOCKUK26, CHIP-BCIS3 chief investigator Professor Divaka Perera will take us through interventional strategies in cardiogenic shock.
Got a case, project or research you want to share?
Bring it to SHOCK 2026.
Trainee, researcher or clinician, if you’re working in cardiogenic shock, ECMO or mechanical circulatory support, we want to hear from you.
Get your abstract in 👇
When conventional CPR fails, can ECMO change the outcome?
Prof Demetris Yannopoulos has been at the forefront of ECPR research, including the landmark ARREST trial.
Pleased to welcome him to UK SHOCK 26.
#ECPR #ECMO #CardiacArrest #CardiogenicShock
Cardiogenic shock: we’ve come a long way, but there are still more questions than answers.
Looking forward to some interesting discussions at SHOCK 2026.
How do you change critical care across an entire health service?
During COVID-19 pandemic, critical care had to rapidly expand capacity while facing shortages of staff, equipment and medicines 😐- and limited knowledge of a new disease🤒.
UK SHOCK 26 4-5 December 2026
@RCPhysicians London
Our national summit on cardiac arrest and cardiogenic shock
Professor Jacob Møller will present “Learning from DanGer Shock” at #SHOCKUK26.
What have we learned from DanGer Shock - and what questions remain?🤔
⏰ Less than 48 hours left!
Early Bird ends 31 August - don’t miss your chance to grab your #UKSHOCK26 tickets at the best price! 🎟️ 🎟️
